SCHEMBL2806312

SCHEMBL2806312

CC(=CC(=O)c1ccccc1)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 19/20 1.00
▸ PPARA Q07869 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806311 1.00 PPARG (1.00) PPARGPPARA
SCHEMBL4158584 1.00 PPARG (1.00) PPARGPPARA
SCHEMBL2805642 0.91 PPARG (1.00) PPARGPPARA
SCHEMBL2805640 0.91 PPARG (1.00) PPARGPPARA
SCHEMBL7711541 0.90 PPARG (0.80) PPARGPPARA
SCHEMBL7711546 0.90 PPARG (0.80) PPARGPPARA
SCHEMBL28303067 0.83 PPARG (0.76) PPARGPPARA
SCHEMBL6182299 0.82 GPR132 (0.77) PPARG
SCHEMBL27871431 0.82 GPR132 (0.77) PPARG
SCHEMBL6605281 0.82 PPARG (0.86) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020137794-A1 Retinoic acid receptor (RAR) agonists, agonists for steroid/thyroid hormone receptor superfamily, and an agonist for a heterodimer partner SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE 2002-09-26 — — US claimed
US-6436993-B1 SYNERGISTIC MIXTURES OF RETINOIC ACID RECEPTOR (RAR) ANTAGONISTS AND STEROID, THYROID OR RETINOID RECEPTOR AGONISTS SUCH AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS USED TO CONTROL CELLULAR PROCESSES THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 2002-08-20 — — US claimed
WO-2001003659-A1 USE OF RAR ANTAGONISTS AS MODULATORS OF HORMONE MEDIATED PROCESSES THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2001-01-18 — — WO claimed
US-20110300129-A1 SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY UNIVERSITY OF ROCHESTER (US) 2011-12-08 — — US disclosed
WO-2010075037-A1 SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY UNIVERSITY OF ROCHESTER (US) 2010-07-01 — — WO disclosed
EP-2081599-A2 COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION University of Debrecen (HU) 2009-07-29 — — EP disclosed
US-20090155228-A1 COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION UNIVERSITY OF DEBRECEN (HU) 2009-06-18 — — US disclosed
WO-2007144679-A2 COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION UNIVERSITY OF DEBRECEN (HU) 2007-12-21 — — WO disclosed
US-20020137794-A1 Retinoic acid receptor (RAR) agonists, agonists for steroid/thyroid hormone receptor superfamily, and an agonist for a heterodimer partner SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE 2002-09-26 — — US disclosed
US-6436993-B1 SYNERGISTIC MIXTURES OF RETINOIC ACID RECEPTOR (RAR) ANTAGONISTS AND STEROID, THYROID OR RETINOID RECEPTOR AGONISTS SUCH AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS USED TO CONTROL CELLULAR PROCESSES THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 2002-08-20 — — US disclosed
WO-2001003659-A1 USE OF RAR ANTAGONISTS AS MODULATORS OF HORMONE MEDIATED PROCESSES THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2001-01-18 — — WO disclosed
Send feedback